A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer (CAPTAIN)
Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
Sponsor: Profound Medical Inc.
Listed as NCT05027477, this NA trial focuses on Prostate Adenocarcinoma and Prostate Cancer and remains ongoing. Sponsored by Profound Medical Inc., it has been updated 21 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2025 — Sep 2025 [monthly]
Recruiting NA
-
Feb 2025 — Mar 2025 [monthly]
Recruiting NA
-
Dec 2024 — Feb 2025 [monthly]
Recruiting NA
-
Sep 2024 — Dec 2024 [monthly]
Recruiting NA
▶ Show 16 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
-
Jan 2024 — Feb 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jan 2024 [monthly]
Recruiting NA
-
Nov 2023 — Dec 2023 [monthly]
Recruiting NA
-
Sep 2023 — Nov 2023 [monthly]
Recruiting NA
-
Jun 2023 — Sep 2023 [monthly]
Recruiting NA
-
May 2023 — Jun 2023 [monthly]
Recruiting NA
-
Dec 2022 — May 2023 [monthly]
Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
-
Feb 2022 — Apr 2022 [monthly]
Recruiting NA
-
Dec 2021 — Feb 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Profound Medical Inc.
For direct contact, visit the study record on ClinicalTrials.gov .